SynLaD: Latent Diffusion for Generating Synthesizable Molecules Conditioned on 3D Pharmacophore Profiles
Focuses on SynLaD: Latent Diffusion for Generating Synthesizable Molecules Conditioned on 3D Pharmacophore Profiles.
At a glance
- Source
- arXiv
- Published
- Jul 2, 2026
- Read time
- 1 min read
- Primary lane
- Machine Learning
Quick read
3 bullets- Focuses on SynLaD: Latent Diffusion for Generating Synthesizable Molecules Conditioned on 3D Pharmacophore Profiles.
- We present SynLaD, a latent diffusion framework for small-molecule generation that unifies ligand-based drug design objectives (what to make) with synthetic accessibility (how to make it).
- Current models typically optimize one objective at the expense of the other, creating a bottleneck for discovering high-scoring and synthesizable molecules.
Why it matters
Clinical and bio workflows punish fragile models quickly. What matters here is whether the method improves trust, robustness, or operational cost enough to make it usable in expensive real settings.
Builder takeaway
arXiv published this update in the Machine Learning lane. Use the original source for details, then compare it with related briefings before changing a roadmap, workflow, or production system.
Clinical and bio workflows punish fragile models quickly. What matters here is whether the method improves trust, robustness, or operational cost enough to make it usable in expensive real settings.
Stay ahead with daily AI briefings
Follow the feed, share the briefing, or jump back into the archive.